Exact Mass: 334.9817482000001
Exact Mass Matches: 334.9817482000001
Found 65 metabolites which its exact mass value is equals to given mass value 334.9817482000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Zoxamide
4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
C14H9NO7S (335.00997240000004)
S-sulfanylglutathione
C10H13N3O6S2 (335.02457580000004)
S-sulfanylglutathione is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. S-sulfanylglutathione is slightly soluble (in water) and a moderately acidic compound (based on its pKa). S-sulfanylglutathione can be found in a number of food items such as oil-seed camellia, apple, rapini, and angelica, which makes S-sulfanylglutathione a potential biomarker for the consumption of these food products.
5-(2,4-Dichlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole
C14H7Cl2N3O3 (334.98644520000005)
(4-Bromophenyl)(4-trifluoromethylpiperidin-1-yl)methanone
C13H13BrF3NO (335.01325440000005)
Lobenzarit sodium
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
N-(4-Bromophenyl)-1,1-diphenylmethanimine
C19H14BrN (335.03095440000004)
3-(6-IODO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-PHENYLAMINE
C13H10IN3 (334.99194500000004)
2-METHYL-3-ETHYL-6-METHOXY BENZOTHIAZOLIUM IODIDE
C11H14INOS (334.98408240000003)
1-[2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2,5-DIMETHYL-1H-PYRROLE-3-CARBALDEHYDE
C14H10Cl2F3NO (335.00915060000005)
3-Bromo-9-(4-methylphenyl)-9H-carbazole
C19H14BrN (335.03095440000004)
4-[(3-Bromo-4-methoxyphenyl)sulfonyl]morpholine
C11H14BrNO4S (334.98268640000003)
4-[(5-Bromo-2-methoxyphenyl)sulfonyl]morpholine
C11H14BrNO4S (334.98268640000003)
4-Bromo-7-chloro-8-fluoro-2-phenylquinoline
C15H8BrClFN (334.95126300000004)
8-BROMO-4-(METHYLTHIO)-7-PHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-AMINE
C12H10BrN5S (334.98402400000003)
3-[4-[(4-CHLOROPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID
7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
C16H8ClF2NO3 (335.01607520000005)
4-BENZYL-5-(2,4-DICHLOROPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL
C15H11Cl2N3S (335.00507060000007)
5-Bromo-1-(4-nitrophenyl)-3-(trifluoromethyl)-1h-pyrazole
3-(2,4-dichlorophenyl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione
C15H11Cl2N3S (335.00507060000007)
3,4-dichloro-N-(4-chlorophenyl)benzenesulphonamide
C12H8Cl3NO2S (334.93413180000005)
5-BROMO-3-TERT-BUTOXYCARBONYLAMINO-THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
C11H14BrNO4S (334.98268640000003)
2-(2,4-Dichlorophenyl)-α-methyl-6-benzoxazoleacetic acid
C16H11Cl2NO3 (335.0115956000001)
5-(bromomethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole
C12H9BrF3NS (334.95911300000006)
3,4-Difluoro-N-(6-nitro-2-benzothiazolyl)benzamide
methyl 4-[2-hydroxyethyl(methyl)amino]-3-iodobenzoate
3-(5,6-dichloro-1H-indol-2-yl)-4-methoxybenzoic acid
C16H11Cl2NO3 (335.0115956000001)
3-[2-[(4-CHLOROPHENYL)THIO]-5-NITROPHENYL]ACRYLIC ACID
8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one
3-iodo-4-[(2-methoxyacetyl)amino]benzoic acid
C10H10INO4 (334.9654570000001)
4-[[2-hydroxyethyl(methyl)amino]methyl]-3-iodobenzoic acid
Meclofenamate sodium
C14H12Cl2NNaO3 (335.00919020000003)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid
C14H9NO7S (335.00997240000004)
3-(4-bromophenyl)-4-(2-furanylmethyl)-1H-1,2,4-triazole-5-thione
C13H10BrN3OS (334.97279100000003)
2-(Carboxymethyl)-1-Oxo-1,2-Dihydronaphtho[1,2-D]isothiazole-4-Carboxylic Acid 3,3-Dioxide
C14H9NO7S (335.00997240000004)
2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]imidazol-4-yl]acetate
2-[[(3-Bromophenyl)-oxomethyl]amino]-5-hydroxybenzoic acid
C14H10BrNO4 (334.97931600000004)
5-(5-Bromo-2-chlorophenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
C13H7BrClN3O (334.94609820000005)
(4Z)-4-[(7-methoxy-1,3-benzodioxol-5-yl)methylidene]-2-prop-2-enylsulfanyl-1,3-thiazol-5-one
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
1-(5-Bromo-2-pyridinyl)-3-(2-methoxy-5-methylphenyl)urea
[1-(5-Phosphonatoribosyl)imidazol-4-yl]acetate(3-)
2-(4-Methylphenyl)-6-(methylthio)-4-(trichloromethyl)-1,4-dihydro-1,3,5-triazine
C12H12Cl3N3S (334.9817482000001)
[(Z)-(7,7-dioxo-5,6-dihydrothieno[2,3-b]thiopyran-4-ylidene)amino] 2-methylbenzoate
HIF-2α-IN-3
HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 μM and a KD of 1.1 μM. Anticancer agent[1].